Mike Rasenberg
Overview
Explore the profile of Mike Rasenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paul Friedman K, Thomas R, Wambaugh J, Harrill J, Judson R, Shafer T, et al.
Toxicol Sci
. 2025 Feb;
PMID: 39969258
Use of new approach methods (NAMs), including high-throughput, in vitro bioactivity data, in setting a point-of-departure (POD) will accelerate the pace of human health hazard assessments. Combining hazard and exposure...
2.
Tarazona J, Fernandez-Agudo A, Adamovsky O, Baccaro M, Burden N, Campos B, et al.
Regul Toxicol Pharmacol
. 2025 Jan;
156:105774.
PMID: 39855421
Environmental Safety Assessments (ESA) are mandatory for several regulatory purposes and are an important component of stewardship/sustainability initiatives. Fish testing is used for assessing chemical toxicity and bioaccumulation potential; amphibians...
3.
Paul Friedman K, Gagne M, Loo L, Karamertzanis P, Netzeva T, Sobanski T, et al.
Toxicol Sci
. 2019 Sep;
173(1):202-225.
PMID: 31532525
Use of high-throughput, in vitro bioactivity data in setting a point-of-departure (POD) has the potential to accelerate the pace of human health safety evaluation by informing screening-level assessments. The primary...
4.
Laroche C, Annys E, Bender H, Botelho D, Botham P, Brendler-Schwaab S, et al.
Regul Toxicol Pharmacol
. 2019 Sep;
108:104470.
PMID: 31479718
The European Partnership for Alternative Approaches to Animal Testing (EPAA) convened a Partners' Forum on repeated dose toxicity (RDT) testing to identify synergies between industrial sectors and stakeholders along with...
5.
Karamertzanis P, Atlason P, Nathanail A, Provoost J, Karhu E, Rasenberg M
Regul Toxicol Pharmacol
. 2019 May;
106:303-315.
PMID: 31085250
The present study primarily aims at informing regulators and policy makers in Europe and examines the evolution of self-classifications and study availability for the endpoints of carcinogenicity, mutagenicity, reproductive toxicity...
6.
Alasuvanto T, Gissi A, Sobanski T, Karamertzanis P, Rasenberg M
Methods Mol Biol
. 2018 Jun;
1800:107-115.
PMID: 29934889
REACH is a regulation of the European Union adopted to improve the safe use of chemicals with regard to human health and the environment. The safe use of chemicals can...
7.
Kavlock R, Bahadori T, Barton-Maclaren T, Gwinn M, Rasenberg M, Thomas R
Chem Res Toxicol
. 2018 Mar;
31(5):287-290.
PMID: 29600706
Changes in chemical regulations worldwide have increased the demand for new data on chemical safety. New approach methodologies (NAMs) are defined broadly here as including in silico approaches and in...
8.
Dimitrov S, Georgieva D, Pavlov T, Karakolev Y, Karamertzanis P, Rasenberg M, et al.
Environ Toxicol Chem
. 2015 Jun;
34(11):2450-62.
PMID: 26053589
Substances of unknown or variable composition, complex reaction products, or biological materials (UVCBs) have been conventionally described in generic terms. Commonly used substance identifiers are generic names of chemical classes,...